| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |